Literature DB >> 30706694

Role of gut microbial metabolites in nonalcoholic fatty liver disease.

Ze Hua Zhao1, Jonathan King-Lam Lai2, Liang Qiao2, Jian Gao Fan1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common, multifactorial liver disease that has emerged as a global challenge due to its increasing prevalence and lack of sustainable treatment options. Gut microbiota possess vital functions in fermenting dietary nutrients and synthesizing bioactive molecules. This function is of great importance in maintaining health because these microbial metabolites are essential in regulating energy metabolism, immune response, and other vital physiological processes. Altered gut flora can result in a change in gut microbial metabolites, affecting the onset and progression of multiple diseases. In this review we summarize the metabolites that may have beneficial or harmful effects on the development and progression of NAFLD. This will help us better understand the possible mechanisms underlying the pathogenesis of NAFLD and facilitate the identification of potential therapeutic approaches for NAFLD.
© 2019 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  diet; gastrointestinal microbiome; gut-liver axis; metabolite; non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2019        PMID: 30706694     DOI: 10.1111/1751-2980.12709

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  5 in total

Review 1.  Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases.

Authors:  Charlotte Teunis; Max Nieuwdorp; Nordin Hanssen
Journal:  Metabolites       Date:  2022-06-02

2.  Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma.

Authors:  Ashraf Khalil; Azza ElSheashaey; Eman Abdelsameea; Manar Obada; Mohamed Bayomy F F; Hala El-Said
Journal:  Br J Biomed Sci       Date:  2022-01-10       Impact factor: 2.432

3.  Tributyrin Attenuates Metabolic and Inflammatory Changes Associated with Obesity through a GPR109A-Dependent Mechanism.

Authors:  Fabio Takeo Sato; Yu Anne Yap; Amanda Rabello Crisma; Mariana Portovedo; Gilson Masahiro Murata; Sandro Massao Hirabara; Willian Rodrigues Ribeiro; Caroline Marcantonio Ferreira; Maysa Mariana Cruz; Joice Naiara Bertaglia Pereira; Tanyara Baliani Payolla; Suzana Eiko Sato Guima; Andrew Maltez Thomas; João Carlos Setubal; Maria Isabel Cardoso Alonso-Vale; Marinilce Fagundes Santos; Rui Curi; Eliana Marino; Marco A R Vinolo
Journal:  Cells       Date:  2020-09-01       Impact factor: 6.600

Review 4.  Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine.

Authors:  Hao Cheng; Juan Liu; Yuzhu Tan; Wuwen Feng; Cheng Peng
Journal:  J Pharm Anal       Date:  2021-10-21

5.  Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis.

Authors:  Dengcheng Zhou; Jing Zhang; Chengju Xiao; Chunheng Mo; Bi-Sen Ding
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.